Updated September 16, 2026
Want the number for your practice? Get a free confidential valuation →
Every multiple you have ever heard quoted is applied to adjusted EBITDA, and for dental practices that calculation has one step that regularly surprises owners. Buyers start with collections and subtract real operating costs — including a market-rate associate wage for the dentistry you personally produce. If you collect $900K of your own production, a buyer prices the practice as if it had to pay a dentist to do that work, because after closing, it does. Then they add back the owner-specific costs that will not continue: compensation you take above that clinical wage, family members on payroll, personal expenses run through the practice, one-time costs.
The result is usually a smaller number than the owner’s take-home — and it is the honest denominator. A practice “offered 6x” on a generous EBITDA definition can be worth less in dollars than one offered 5x on a rigorous one, which is the first reason quoted multiples travel so poorly between practices. Our plain-language guide to adjusted EBITDA and add-backs covers which adjustments hold up in diligence.
| Practice profile | Typical range (× adjusted EBITDA) |
|---|---|
| Smaller solo practices | 3.5–5× |
| Established general practices | 4.5–6.5× |
| Larger, multi-provider or multi-site practices | 5.5–8× |
Industry rule-of-thumb ranges — the same ranges used in our free valuation calculator and our EBITDA multiples by industry guide — not an appraisal of your practice.
Size moves the range because size usually means the practice runs with less of you in it: associates producing, hygiene humming, a manager managing. Buyers are not paying for square footage; they are paying for earnings that survive your exit.
Inside each range, the same handful of fundamentals decides whether a practice prices at the bottom or the top:
DSOs and platform groups underwrite your practice as an add-on: they apply their own overhead assumptions, price your EBITDA after integration, and can reach the top of the range for practices with strong hygiene and associate coverage. But the structure is where the differences live. DSO consideration frequently includes rollover equity in the parent, earn-outs tied to your continued production, and holdbacks — terms that vary enormously between groups and that convert a headline “7x” into something that depends on years of future events. Private buyers and individual dentists typically offer lower headlines with more cash at close, stronger cultural continuity, and fewer strings; financing contingencies make process discipline matter more, not less.
Neither is categorically better. The point is that offers must be compared on structure and after-tax cash across time, not on the multiple printed in the first paragraph — and that comparing them properly requires having more than one. If the DSO question is live for you, the fuller treatment is in Should I sell my dental practice to a DSO? and, if a letter has already landed, what to do with an unsolicited DSO offer.
Owners negotiate the multiple because it is visible; sophisticated buyers negotiate the structure because it is where the money actually moves. Consider the components separately. Cash at close is the only number that is certain. Rollover equity can be a genuine second bite — owners who rolled into well-run groups have done very well — or it can be illiquid paper in a leveraged vehicle you cannot value from the outside; the difference is in the operating agreement, not the pitch deck. Earn-outs tied to your continued production are, functionally, a wage with your sale proceeds at stake — read the cliff terms and ask what happens if you get sick. Real estate deserves its own negotiation entirely: whether the buyer purchases the building, signs a long lease, or something in between routinely moves more total dollars than a half-turn of multiple. Two offers with identical headlines can differ by a third in risk-adjusted value once these are laid side by side — which is the strongest practical argument for having more than one offer to lay.
The multiple you get in eighteen months is being manufactured in your practice today. Hygiene reactivation, associate development, payor-mix cleanup, and clean financials all need time to appear in the trailing numbers a buyer will underwrite. The owners who do best treat the valuation conversation as a planning tool, not a trigger: knowing your number and its two or three movable levers, years before you sell, costs nothing and forecloses nothing.
Valuation curiosity should never become market rumor. In a properly run process, buyers — DSOs included — are qualified and sign NDAs before they learn your practice’s name; nothing is listed or advertised anywhere; and information about your team and your patients is released in stages, late, and under tighter terms. Your staff, your patients, and the practice down the street hear nothing until you decide they should. Even the first step is private by design: a valuation conversation with us is free, creates no obligation, and is shared with no one.
As an industry rule of thumb, smaller solo practices trade around 3.5x to 5x adjusted EBITDA, established general practices around 4.5x to 6.5x, and larger multi-provider or multi-site practices around 5.5x to 8x. The same practice can price very differently by buyer type, payor mix, hygiene strength, and how the process is run — which is why the multiple in any single unsolicited offer tells you very little.
No. Buyers start from collections, subtract real operating costs including a market-rate wage for the dentistry you personally produce, then add back owner-specific expenses that will not continue — above-market salary beyond that clinical wage, family payroll, personal costs run through the practice. The result, adjusted EBITDA, is usually smaller than owners expect precisely because of the replacement-dentist wage, and it is the number every multiple is applied to.
Often on headline price, not always on real terms. DSOs underwrite your practice as an add-on and can pay top-of-range multiples, but part of the consideration frequently arrives as rollover equity, earn-outs, or holdbacks tied to your continued production. A private buyer’s lower headline can deliver similar or better cash at close with fewer strings. Comparing offers on structure, not multiple, is most of the work.
The levers with real runway are hygiene reactivation and program strength, reducing your personal share of production by developing associates, cleaning up payor mix where possible, and keeping two to three years of clean, consistent financials. Most of these take twelve to twenty-four months to show in the numbers, which is why the valuation conversation is worth having before you are ready to sell.